ProfileGDS4718 / 235255_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 49% 46% 44% 45% 47% 54% 46% 44% 48% 51% 50% 47% 47% 48% 47% 50% 48% 44% 51% 28% 42% 48% 48% 52% 47% 54% 52% 46% 42% 47% 45% 53% 45% 47% 46% 55% 45% 38% 47% 40% 47% 39% 40% 49% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.4446549
GSM549102patient 115, normal, homogenized [OPG study]5.3210946
GSM549104patient 119, normal, homogenized [OPG study]5.1567144
GSM549108patient 138, normal, homogenized [OPG study]5.2990345
GSM549119patient 077, normal, homogenized [OPG study]5.3511147
GSM549133patient 032, cancer, homogenized [OPG study]5.7141554
GSM549139patient 042, cancer, homogenized [OPG study]5.261646
GSM549099patient 107, normal, homogenized [OPG study]5.1978744
GSM549109patient 139, normal, homogenized [OPG study]5.40748
GSM549110patient 046, normal, homogenized [OPG study]5.5940851
GSM549114patient 063, normal, homogenized [OPG study]5.4848350
GSM549122patient 082, normal, homogenized [OPG study]5.3339547
GSM549134patient 033, cancer, homogenized [OPG study]5.321647
GSM549136patient 036, cancer, homogenized [OPG study]5.3524348
GSM549140patient 044, cancer, homogenized [OPG study]5.3200147
GSM549111patient 047, normal, homogenized [OPG study]5.4866750
GSM549113patient 057, normal, homogenized [OPG study]5.3324348
GSM549132patient 031, cancer, homogenized [OPG study]5.1843844
GSM549137patient 038, cancer, homogenized [OPG study]5.5794451
GSM549142patient 047, cancer, homogenized [OPG study]4.5727228
GSM549100patient 110, normal, homogenized [OPG study]5.0941542
GSM549107patient 135, normal, homogenized [OPG study]5.393748
GSM549115patient 068, normal, homogenized [OPG study]5.3495348
GSM549116patient 072, normal, homogenized [OPG study]5.6245252
GSM549120patient 078, normal, homogenized [OPG study]5.3480247
GSM549131patient 030, cancer, homogenized [OPG study]5.6949254
GSM549118patient 074, normal, homogenized [OPG study]5.6425452
GSM549129patient 027, cancer, homogenized [OPG study]5.3062346
GSM549123patient 088, normal, homogenized [OPG study]5.0687442
GSM549124patient 006, cancer, homogenized [OPG study]5.3897147
GSM549126patient 015, cancer, homogenized [OPG study]5.2123345
GSM549128patient 025, cancer, homogenized [OPG study]5.663153
GSM549103patient 117, normal, homogenized [OPG study]5.3117745
GSM549117patient 073, normal, homogenized [OPG study]5.330847
GSM549138patient 041, cancer, homogenized [OPG study]5.2894946
GSM549141patient 045, cancer, homogenized [OPG study]5.7774955
GSM549130patient 028, cancer, homogenized [OPG study]5.2663445
GSM549101patient 111, normal, homogenized [OPG study]4.9495538
GSM549105patient 128, normal, homogenized [OPG study]5.3844647
GSM549106patient 134, normal, homogenized [OPG study]4.9642540
GSM549112patient 048, normal, homogenized [OPG study]5.3493647
GSM549125patient 011, cancer, homogenized [OPG study]4.9382639
GSM549127patient 024, cancer, homogenized [OPG study]4.9692840
GSM549135patient 035, cancer, homogenized [OPG study]5.4441149